Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study

Journal of Interventional Cardiac Electrophysiology

Volumn 19, Issue 3, 2007, Pages 201-207

  Maines, Massimiliano ^a   Catanzariti, Domenico ^a   Cemin, Claudio ^a   Vaccarini, Chiara ^a   Vergara, Giuseppe ^a  

^a Ospedale S Maria del Carmine   (Italy)

Author keywords

Biventricular defibrillator; Heart failure; Hospitalizations; Intrathoracic fluids accumulation monitoring

Indexed keywords

ALARM MONITOR; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEFIBRILLATOR; HEART FAILURE; HOSPITALIZATION; HUMAN; HYDROTHORAX; IMPEDANCE; IMPLANTATION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL;

ACOUSTICS; AGED; CARDIAC PACING, ARTIFICIAL; CASE-CONTROL STUDIES; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 35348854915     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-007-9155-4     Document Type: Article

References (28)

1. The CONSENSUS Trial Study Group (1987). Effects of Enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New England Journal of Medicine, 316, 1429-1435.
2. Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., et al. (2000). Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet, 355, 1582-1587.
3. Bristow, M. R. (2000). Beta-adrenergic receptor blockade in chronic heart failure. Circulation, 101, 558-569.
4. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341, 709-717.
5. The Digitalis Investigation group (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine, 336, 525-533.
6. Heart Failure Society of America (HFSA) (1999). HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacologic approaches. Journal of Cardiac Failure, 5, 357-382.
7. Gras, D., Mabo, P., Tang, T., Luttikuis, O., Chatoor, R., Pedersen, A. K., et al. (1998). Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync Study. Pacing and Clinical Electrophysiology, 21, 2249-2255.
8. Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., et al. (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New England Journal of Medicine, 344, 873-880.
9. Young, J. B., Abraham, W. T., Smith, A. L., Leon, A. R., Lieberman, R., Wilkoff, B., et al. (2003). Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. Journal of the American Medical Association, 289, 2685-2694.
10. Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350, 2140-2150.
11. Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539-1549.
12. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al. (2006). Heart disease and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, e85-e151.
13. O'Connell, J. B. (2000). The economic burden of heart failure. Clinical Cardiology, 23(Suppl 3), III6-III10.
14. Sackner-Bernstein, J. (2004). What is heart failure and what are the treatment options? Complex questions. In D. L. Hayes, P. J. Wang, J. Sackner-Bernstein, & S. J. Asirvatham (Eds.), Resynchronization and defibrillation for heart failure (pp. 1-2). Oxford, UK: Blackwell.
15. Wang, L., Lahatinen, S., Lentz, L., Rakow, N., Kaszas, C., Ruetz, L., et al. (2005). Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing and Clinical Electrophysiology, 28, 404-411.
16. Yu, C. M., Wang, L., Chau, E., Chan, R. H., Kong, S. L., Tang, M. O., et al. (2005). Intrathoracic impedance monitoring in patients with heart failure. Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation, 112, 841-848.
17. Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., et al. (2005). Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal, 26, 1115-1140.
18. Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Available at American College of Cardiology Web Site: http://www.acc.org/clinical/guidelines/failure/index.pdf
19. McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971). The natural history of congestive heart failure: The Framingham study. New England Journal of Medicine, 285, 1441-1446.
20. Luepker, R. V., Michael, J. R., & Warbasse, J. R. (1973). Transthoracic electrical impedance: Quantitative evaluation of a non-invasive measure of thoracic fluid volume. American Heart Journal, 65, 83-93.
21. Baker, L. E., & Danniston, J. C. (1974). Noninvasive measurement of intrathoracic fluids. Chest, 65(Suppl), 35S-37S.
22. Sahalos, J. N., Nicolaidis, A., & Gotsis, N. (1986). The electrical impedance of the human thorax as a guide in evaluation of intrathoracic fluid volume? Physics in Medicine & Biology, 31, 425-439.
23. Van de Water, J. M., Moumt, B. E., Barela, J. R., Schuster, R., & Leacook, F. S. (1973). Monitoring the chest with impedance. Chest, 64, 597-603.
24. Jonsson, F., Madsen, P., Jorgensen, L. G., Lunding, M., & Secher, N. H. (1995). Thoracic electrical impedance and fluid balance during aortic surgery. Acta Anaesthesiologica Scandinavica, 39, 513-517.
25. Perko, G., Perko, M., Jansen, E., & Secher, N. H. (1991). Thoracic impedance as an index of body fluid imbalance during cardiac surgery. Acta Anaesthesiologica Scandinavica, 35, 368-571.
26. Jain, P., Massie, B. M., Gattis, W. A., Klein, L., & Gheorghiade, M. (2003). Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. American Heart Journal, 145, S3-S17.
27. Vollmann, D., Nagele, H., Schauerte, P., Wiegand, U., Butter, C., Zanotto, G., et al. (2007). Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal, Feb 19.
28. Ypenburg, C., Bax, J. J., van der Wall, E., Schalij, M. J., & van Erven, L. (2007). Intrathoracic impedance monitoring to predict decompensated heart failure. American Journal of Cardiology, 99, 554-557